secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001193125-24-211066
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences implements 1-for-25 reverse stock split effective August 28, 2024
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-25 ratio effective 8:00 a.m. ET on August 28, 2024.
- No fractional shares issued; cash paid for fractional shares based on Aug 27 closing price.
- CUSIP changed to 34962G 208; trading symbol FBRX unchanged on Nasdaq.
- Proportionate adjustments made to equity incentive plans and outstanding awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312524211066/0001193125-24-211066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312524211066/d838050d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-211066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer